Trial Profile
Evaluation of Nilotinib in Advanced GIST Previously Treated With Imatinib and Sunitinib.
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 26 Apr 2013
Price :
$35
*
At a glance
- Drugs Nilotinib (Primary)
- Indications Gastrointestinal stromal tumours
- Focus Therapeutic Use
- 26 Aug 2011 Status changed from completed to discontinued as reported by ClinicalTrials.gov.
- 03 Feb 2010 Actual end date (Oct 2009) added as reported by ClinicalTrials.gov.
- 03 Feb 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.